Back to top
more

DaVita (DVA)

(Delayed Data from NYSE)

$162.26 USD

162.26
460,647

-1.85 (-1.13%)

Updated Sep 26, 2024 04:00 PM ET

After-Market: $162.26 0.00 (0.00%) 5:52 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 17% (42 out of 252)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Indrajit Bandyopadhyay headshot

Aveanna Stock Rallies 110% in 3 Months: Is It Still Worth Buying?

AVAH stock has the potential to continue its uptrend on the back of a better payer rate environment and its focus on high-paying customers.

Nalak Das headshot

2 Must-Buy Medical Stocks With Strong Momentum

Two medical stocks with strong momentum and a favorable Zacks Rank are: DVA, ILMN.

Reasons to Retain Stryker Stock in Your Portfolio for Now

SYK continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.

Reasons to Retain Fresenius Medical Stock in Your Portfolio Now

FMS continues to gain traction through its broad dialysis product and service portfolio. Ongoing macro challenges raise concerns.

Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

MCK Stock's Uptrend Likely to Continue After Core Ventures Acquisition

McKesson's agreement to acquire a controlling interest will likely bring advanced treatments and improved care experiences to patients.

Looking for Medical Stocks? The Zacks Rank Can Help You Find Winners

The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

Best Momentum Stock to Buy for August 27th

DVA, MRX and AIZ made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 27, 2024.

Is DaVita (DVA) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?

Here is how Adagene Inc. Sponsored ADR (ADAG) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.

Reasons to Add The Cooper Companies (COO) to Your Portfolio Now

The Cooper Companies (COO) benefits from strength in its business segments. Its acquisitions are likely to drive the top line. A rise in selling, general and administrative expenses is, however, concerning.

Inogen (INGN) Rises 127% Year to Date: What's Driving the Stock?

Expanding product portfolio and high prospects for POC raise optimism for the Inogen (INGN) stock.

Glaukos (GKOS) Gains 63.5% YTD: What's Driving the Stock?

Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.

Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run?

Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Alcon (ALC) Q2 Earnings Meet Estimates, Revenues Increase Y/Y

Alcon (ALC) delivers impressive growth in Implantables and Contact Lenses in the second quarter of 2024.

Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now

Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

Here's Why You Should Retain Nevro (NVRO) Stock for Now

Strength in Nevro's (NVRO) Senza Platform raises optimism about the stock.

Why You Should Add HCA Healthcare (HCA) to Your Portfolio Now

HCA Healthcare (HCA) remains well-poised for growth on growing emergency room visits, buyouts and solid cash flows.

GE HealthCare's (GEHC) Tie-Up to Boost Female Pelvic Healthcare

GE HealthCare's (GEHC) latest collaboration is likely to equip clinicians with a toolset to deliver enhanced care to female patients and improve the patient experience.

Avantor (AVTR) Inks Deal to Optimize Portfolio, Reduce Debt

Avantor's (AVTR) latest agreement is likely to enhance its focus on strategic growth opportunities and reduce its debt burden.

Vasundhara Sawalka headshot

4 Stocks Trading Near 52-Week High With More Upside Potential

Investors target stocks that have lately been on a bull run. Stocks like PPC, THC, DVA and UHS are seeing price strength and have a high chance of carrying the momentum forward.

Masimo (MASI) Gets New Suitors for Its Consumer Business Sale

Masimo (MASI) receives unsolicited requests from multiple entities for acquiring its consumer business. The company already received a non-binding term sheet confirmation from a third party in May.

Reasons to Add Intuitive Surgical (ISRG) to Your Portfolio Now

Intuitive Surgical (ISRG) continues to raise optimism among investors owing to its strength in robotics.

DaVita Inc. (DVA) Hits Fresh High: Is There Still Room to Run?

DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Accuray (ARAY) Q4 Earnings Lag Estimates, Gross Margin Shrinks

Despite improving product sales, Accuray (ARAY) reports mixed fourth-quarter fiscal 2024 results.